Compare Stocks → Move Your Money Before May 22 (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:FIRETSE:HLSCVE:NXSTSE:TGOD Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFIRE(FIRE)$0.00$0.00▼$0.00N/AN/AN/AN/AHLSHLS TherapeuticsC$4.65-1.7%C$4.31C$3.34▼C$7.12C$148.43M1.169,382 shs700 shsNXSNexus GoldC$0.02C$0.02C$0.02▼C$0.10C$628K0.8566,764 shs50,800 shsTGODGreen Organic DutchmanC$0.17C$0.17▼C$0.65C$89.95MN/A2.66 million shs19.70 million shs7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFIRE(FIRE)0.00%0.00%0.00%0.00%0.00%HLSHLS Therapeutics-0.42%-3.86%+31.02%+15.65%-18.17%NXSNexus Gold0.00%-25.00%-25.00%0.00%+200.00%TGODGreen Organic Dutchman0.00%0.00%0.00%0.00%0.00%The Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFIRE(FIRE)N/AN/AN/AN/AN/AN/AN/AN/AHLSHLS Therapeutics0.0645 of 5 stars1.10.01.70.00.60.80.0NXSNexus GoldN/AN/AN/AN/AN/AN/AN/AN/ATGODGreen Organic DutchmanN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFIRE(FIRE)N/AN/AN/AN/AHLSHLS Therapeutics2.25HoldC$4.58-1.61% DownsideNXSNexus GoldN/AN/AN/AN/ATGODGreen Organic DutchmanN/AN/AN/AN/ACurrent Analyst RatingsLatest NXS, HLS, TGOD, and FIRE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/18/2024HLSHLS TherapeuticsRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetC$6.50 ➝ C$5.003/15/2024HLSHLS TherapeuticsStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetC$4.35 ➝ C$4.152/22/2024HLSHLS TherapeuticsStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetC$5.00 ➝ C$4.352/6/2024HLSHLS TherapeuticsClarus SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFIRE(FIRE)N/AN/AN/AN/AN/AN/AHLSHLS TherapeuticsC$63.07M2.35C$0.31 per share15.22C$3.06 per share1.52NXSNexus GoldN/AN/AC$0.00 per share10.00C($0.01) per shareN/ATGODGreen Organic DutchmanC$31.37M0.00N/A10.63C$0.26 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFIRE(FIRE)N/AN/A0.00N/AN/AN/AN/AN/AN/AHLSHLS Therapeutics-C$27.53M-C$1.16N/A∞N/A-43.65%-24.69%-2.87%5/9/2024 (Estimated)NXSNexus Gold-C$1.92M-C$0.06N/A∞N/AN/A-1,307.50%-53.77%5/29/2024 (Estimated)TGODGreen Organic DutchmanN/A-C$0.26N/AN/AN/AN/AN/AN/AN/ALatest NXS, HLS, TGOD, and FIRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/14/2024Q4 2023HLSHLS Therapeutics-C$0.13-C$0.18-C$0.05-C$0.13C$21.83 millionC$21.60 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFIRE(FIRE)N/AN/AN/AN/AN/AHLSHLS TherapeuticsC$0.204.30%N/AN/A N/ANXSNexus GoldN/AN/AN/AN/AN/ATGODGreen Organic DutchmanN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFIRE(FIRE)N/AN/AN/AHLSHLS Therapeutics89.691.651.01NXSNexus Gold14,120.330.050.38TGODGreen Organic Dutchman16.771.280.50OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFIRE(FIRE)N/AHLSHLS Therapeutics59.62%NXSNexus GoldN/ATGODGreen Organic DutchmanN/AInsider OwnershipCompanyInsider OwnershipFIRE(FIRE)N/AHLSHLS Therapeutics0.49%NXSNexus Gold0.51%TGODGreen Organic DutchmanN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableFIRE(FIRE)N/AN/AN/ANot OptionableHLSHLS Therapeutics9131.92 millionN/ANot OptionableNXSNexus GoldN/A41.87 millionN/ANot OptionableTGODGreen Organic Dutchman41529.14 millionN/ANot OptionableNXS, HLS, TGOD, and FIRE HeadlinesSourceHeadlineAnne-Marie Greencbsnews.com - April 23 at 9:57 AMGreen Organic Dutchman (TSE:TGOD) Trading Down 2.9%americanbankingnews.com - April 23 at 1:28 AMOrganic green smoothies for kidsnzherald.co.nz - March 31 at 10:39 AMNorris Greenliverpoolecho.co.uk - February 1 at 2:01 PMGreen beans recipesbbc.co.uk - December 22 at 1:08 AMCannabis producer Bzam ‘dramatically reduces’ head count after TGOD mergermjbizdaily.com - September 19 at 8:51 PMBZAM Ltd. Reports First Quarter 2023 Financial Results; Achieves Record Revenuesbenzinga.com - May 30 at 7:09 PMBZAM cannabis stock keeps Speculative Buy rating with Claruscantechletter.com - May 2 at 9:03 PMBZAM is a double in Canadian cannabis, says Claruscantechletter.com - March 30 at 10:51 PMThe Green Organic Dutchman Announces Effective Date of Name Change to BZAM Ltd. And New Appointment to its Board of Directorsfinance.yahoo.com - February 21 at 8:39 AMCannabis company The Green Organic Dutchman Holdings changing name to BZAMca.finance.yahoo.com - January 25 at 1:22 PMThe Green Organic Dutchman Releases Escrowed Shares And Issues New Sharesmsn.com - January 23 at 12:36 PMThe Green Organic Dutchman Holdings Ltd (TGOD-WR.CN)finance.yahoo.com - January 2 at 8:14 PMThe Green Organic Dutchman Closes $5M Public Offeringmsn.com - December 22 at 12:52 PMThe Green Organic Dutchman Holdings Ltd. Announces Closing of Previously Announced Marketed Public Offering of Unitsyahoo.com - December 22 at 12:52 PMCannabis market is consolidating, says Raymond Jamescantechletter.com - October 25 at 4:25 PMThe Green Organic Dutchman Holdings Ltd.: The Green Organic Dutchman Enters Into a Definitive Agreement To Merge With BZAM Cannabisfinanznachrichten.de - October 20 at 12:37 PMThe Green Organic Dutchman signs deal to merge with BZAM Cannabistimescolonist.com - October 19 at 4:11 PMCanadian companies Green Organic Dutchman, BZAM Cannabis to mergemjbizdaily.com - October 19 at 4:11 PMThe Green Organic Dutchman Launches Four New Cannabis Productsmsn.com - September 21 at 1:05 PMThe Green Organic Dutchman launches exciting new products Fall 2022 in British Columbia, Alberta & Ontariofinance.yahoo.com - September 21 at 8:04 AMThe Green Organic Dutchman Closes Sale of HemPoland subsidiaryfinance.yahoo.com - September 6 at 6:01 PMThe Green Organic Dutchman Announces CFO Changefinance.yahoo.com - July 12 at 10:03 PMThe Green Organic Dutchman Holdings Ltd. (TGODF) CEO Sean Bovingdon on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 26 at 4:47 PMNew MarketBeat Followers Over TimeCompany Descriptions(FIRE)NASDAQ:FIRESourcefire, Inc. (Sourcefire) is engaged in the business of delivering intelligent cybersecurity technologies. The Company provides a portfolio of solutions that enables commercial enterprises and government agencies worldwide to manage and minimize cybersecurity risks. Sourcefire provides customers with Agile Security that consists of hardware with embedded software, software and cloud-based solutions. It sells its solutions to a customer base that includes Global 2000 companies, global enterprises, the United States and international government agencies, and small and mid-size businesses. During the year ended December 31, 2012, it generated approximately 67% of the Company's revenue from customers in the United States, and 33% of the Company's revenue from customers outside of the United States. As of December 31, 2012, its product revenue and services revenue represented 61% and 39% of its total revenue, respectively.HLS TherapeuticsTSE:HLSHLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. schizophrenia. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.Nexus GoldCVE:NXSNexus Gold Corp. engages in the exploration and evaluation of mineral properties in West Africa and Canada. The company explores for gold, silver, manganese, bauxite, copper, nickel, lead, zinc, and limestone/marble deposits. Its flagship property is the Bouboulou project located in Burkina Faso, West Africa. The company was incorporated in 2009 and is headquartered in Vancouver, Canada.Green Organic DutchmanTSE:TGODThe Green Organic Dutchman Holdings Ltd., through its subsidiaries, produces and sells organic cannabis in Canada. It offers organic cannabis products, such as cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis to retailers or distributors, and federal licensed entities. The Green Organic Dutchman Holdings Ltd. was incorporated in 2016 and is headquartered in Mississauga, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.